Logo image of OREGE.PA

OREGE (OREGE.PA) Stock Fundamental Analysis

Europe - EPA:OREGE - FR0010609206 - Common Stock

0.316 EUR
0 (-1.25%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, OREGE scores 2 out of 10 in our fundamental rating. OREGE was compared to 40 industry peers in the Commercial Services & Supplies industry. OREGE may be in some trouble as it scores bad on both profitability and health. OREGE is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year OREGE has reported negative net income.
OREGE had a negative operating cash flow in the past year.
In the past 5 years OREGE always reported negative net income.
OREGE had a negative operating cash flow in each of the past 5 years.
OREGE.PA Yearly Net Income VS EBIT VS OCF VS FCFOREGE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

OREGE has a Return On Assets of -78.64%. This is amonst the worse of the industry: OREGE underperforms 87.50% of its industry peers.
Industry RankSector Rank
ROA -78.64%
ROE N/A
ROIC N/A
ROA(3y)-82.82%
ROA(5y)-75.1%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OREGE.PA Yearly ROA, ROE, ROICOREGE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

OREGE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OREGE.PA Yearly Profit, Operating, Gross MarginsOREGE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

2

2. Health

2.1 Basic Checks

OREGE does not have a ROIC to compare to the WACC, probably because it is not profitable.
OREGE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for OREGE remains at a similar level compared to 5 years ago.
OREGE has a worse debt/assets ratio than last year.
OREGE.PA Yearly Shares OutstandingOREGE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OREGE.PA Yearly Total Debt VS Total AssetsOREGE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -17.77, we must say that OREGE is in the distress zone and has some risk of bankruptcy.
OREGE has a Altman-Z score of -17.77. This is amonst the worse of the industry: OREGE underperforms 82.50% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -17.77
ROIC/WACCN/A
WACC2.89%
OREGE.PA Yearly LT Debt VS Equity VS FCFOREGE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

A Current Ratio of 1.39 indicates that OREGE should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.39, OREGE is doing good in the industry, outperforming 65.00% of the companies in the same industry.
OREGE has a Quick Ratio of 1.39. This is a bad value and indicates that OREGE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of OREGE (0.92) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.92
OREGE.PA Yearly Current Assets VS Current LiabilitesOREGE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.35% over the past year.
The Revenue has grown by 141.86% in the past year. This is a very strong growth!
The Revenue has been growing by 26.64% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)16.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.9%
Revenue 1Y (TTM)141.86%
Revenue growth 3Y10.38%
Revenue growth 5Y26.64%
Sales Q2Q%485.38%

3.2 Future

Based on estimates for the next years, OREGE will show a very strong growth in Earnings Per Share. The EPS will grow by 20.42% on average per year.
Based on estimates for the next years, OREGE will show a very strong growth in Revenue. The Revenue will grow by 63.30% on average per year.
EPS Next Y30%
EPS Next 2Y20.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year100%
Revenue Next 2Y63.3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OREGE.PA Yearly Revenue VS EstimatesOREGE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M
OREGE.PA Yearly EPS VS EstimatesOREGE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OREGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OREGE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OREGE.PA Price Earnings VS Forward Price EarningsOREGE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OREGE.PA Per share dataOREGE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as OREGE's earnings are expected to grow with 20.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OREGE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OREGE

EPA:OREGE (9/16/2025, 7:00:00 PM)

0.316

0 (-1.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-29 2025-07-29
Earnings (Next)10-23 2025-10-23
Inst Owners2.87%
Inst Owner ChangeN/A
Ins Owners1.42%
Ins Owner ChangeN/A
Market Cap15.99M
Analysts40
Price Target0.36 (13.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.67%
EPS NY rev (3m)-16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.25
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.06
BVpS-0.98
TBVpS-0.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -78.64%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-82.82%
ROA(5y)-75.1%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 110.63%
Cap/Sales 91.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 0.92
Altman-Z -17.77
F-Score5
WACC2.89%
ROIC/WACCN/A
Cap/Depr(3y)46.99%
Cap/Depr(5y)33.81%
Cap/Sales(3y)42.11%
Cap/Sales(5y)27.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.9%
EPS Next Y30%
EPS Next 2Y20.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)141.86%
Revenue growth 3Y10.38%
Revenue growth 5Y26.64%
Sales Q2Q%485.38%
Revenue Next Year100%
Revenue Next 2Y63.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.94%
OCF growth 3YN/A
OCF growth 5YN/A